Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of special <scp>AT</scp>‐rich sequence‐binding protein 1 (<scp>SATB</scp>1) predicts poor survival in patients with colorectal cancer

12 Oct 2013

Abstract excerpt

AIM: Special AT-rich sequence-binding protein 1 (SATB1) is a cell type-specific matrix attachment region binding protein, functioning as a global genome organizer. This study aims to investigate the expression pattern and the prognostic value of SATB1 in colorectal cancer. METHODS AND RESULTS: Prospectively collected data were obtained and tissue microarrays were constructed from a cohort of 352 patients. SATB1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cell Adhesion Molecules Research
Share to Digestive system and related health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24118100
DOI: 10.1111/his.12295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of special <scp>AT</scp>‐rich sequence‐binding protein 1 (<scp>SATB</scp>1) predicts poor survival in patients with colorectal cancerPMID 24118100Read ↗

Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinomaSemantic proximity Read ↗

SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.Semantic proximity Read ↗

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal CarcinomasSemantic proximity Read ↗

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsSemantic proximity Read ↗

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.Semantic proximity Read ↗

Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic PitfallSemantic proximity Read ↗

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.Semantic proximity Read ↗

Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.Semantic proximity Read ↗

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study.Semantic proximity Read ↗

Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cellsSemantic proximity Read ↗

Genome Organizer SATB1 selectively activates a defined subset of EMT genes driving metastatic breast cancerSemantic proximity Read ↗

Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressive behavior in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.